Related Experiment Video
Updated: Aug 11, 2026

12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Serous otitis media in amyotrophic lateral sclerosis
Auris, Nasus, Larynx
|January 1, 1987
Summary
Serous otitis media (SOM) occurs frequently in patients with amyotrophic lateral sclerosis (ALS). This condition is primarily linked to muscular dysfunction of the eustachian tube caused by ALS.
Area of Science:
- Otolaryngology
- Neurology
Background:
- Serous otitis media (SOM) is a prevalent condition with often unclear etiology.
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord.
Purpose of the Study:
- To investigate the incidence of SOM in patients diagnosed with ALS.
- To explore the potential relationship between ALS and the development of SOM.
Main Methods:
- The study reports a high incidence of SOM among ALS patients.
- A comparative analysis was conducted between ALS patients and individuals with other diseases to assess SOM prevalence.
Main Results:
- A significantly higher incidence of SOM was observed in patients with ALS compared to other disease groups.
- The primary contributing factor identified for SOM in ALS appears to be muscular dysfunction of the eustachian tube secondary to the disease.
Conclusions:
- Muscular disturbance of the eustachian tube due to ALS is the likely main cause of SOM in these patients.
- While other factors like prolonged supine positioning and nasogastric tube use may play a role, they are considered secondary to the primary muscular issue.
More Related Videos
Related Concept Videos
Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

